David P. Southwell - Chief Executive Officer, Director at TScan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
TCRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David P. Southwell since 7/8/2023

Holdings reported by David P. Southwell for TScan Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Voting Common Stock 171,569 $852 K $4.97 May 18, 2022 Direct
Stock Option (Right to Buy) 100,000 Feb 2, 2023 Direct Voting Common Stock

Transactions reported by David P. Southwell for TScan Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership